Schering Subsidiary Takes Fall For Criminal Charges Under DoJ Settlement
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough's settlement of off-label promotion and Medicaid fraud charges with the Boston U.S. Attorney's office places criminal responsibility with a Schering shell subsidiary
You may also be interested in...
DOJ To Expand Use Of False Claims Act To Manufacturing And AER Violations
Drug manufacturers that sell to the government products that do not meet specifications or that fail to report serious adverse events could face False Claims Act allegations and potentially severe penalties in the near future
DOJ To Expand Use Of False Claims Act To Manufacturing And AER Violations
Drug manufacturers that sell to the government products that do not meet specifications or that fail to report serious adverse events could face False Claims Act allegations and potentially severe penalties in the near future
DOJ To Expand Use Of False Claims Act To Manufacturing And AER Violations
Drug manufacturers that sell to the government products that do not meet specifications or that fail to report serious adverse events could face False Claims Act allegations and potentially severe penalties in the near future